Find information on thousands of medical conditions and prescription drugs.

Alcaine

A topical eye anesthetic is a topical anesthetic that is used to numb the surface of the eye. Examples of topical eye anesthetics are oxybuprocaine, tetracaine, alcaine, proxymetacaine and proparacaine. more...

Home
Diseases
Medicines
A
8-Hour Bayer
Abacavir
Abamectin
Abarelix
Abciximab
Abelcet
Abilify
Abreva
Acamprosate
Acarbose
Accolate
Accoleit
Accupril
Accurbron
Accure
Accuretic
Accutane
Acebutolol
Aceclidine
Acepromazine
Acesulfame
Acetaminophen
Acetazolamide
Acetohexamide
Acetohexamide
Acetylcholine chloride
Acetylcysteine
Acetyldigitoxin
Aciclovir
Acihexal
Acilac
Aciphex
Acitretin
Actifed
Actigall
Actiq
Actisite
Actonel
Actos
Acular
Acyclovir
Adalat
Adapalene
Adderall
Adefovir
Adrafinil
Adriamycin
Adriamycin
Advicor
Advil
Aerobid
Aerolate
Afrinol
Aggrenox
Agomelatine
Agrylin
Airomir
Alanine
Alavert
Albendazole
Alcaine
Alclometasone
Aldomet
Aldosterone
Alesse
Aleve
Alfenta
Alfentanil
Alfuzosin
Alimta
Alkeran
Alkeran
Allegra
Allopurinol
Alora
Alosetron
Alpidem
Alprazolam
Altace
Alteplase
Alvircept sudotox
Amantadine
Amaryl
Ambien
Ambisome
Amfetamine
Amicar
Amifostine
Amikacin
Amiloride
Amineptine
Aminocaproic acid
Aminoglutethimide
Aminophenazone
Aminophylline
Amiodarone
Amisulpride
Amitraz
Amitriptyline
Amlodipine
Amobarbital
Amohexal
Amoxapine
Amoxicillin
Amoxil
Amphetamine
Amphotec
Amphotericin B
Ampicillin
Anafranil
Anagrelide
Anakinra
Anaprox
Anastrozole
Ancef
Android
Anexsia
Aniracetam
Antabuse
Antitussive
Antivert
Apidra
Apresoline
Aquaphyllin
Aquaphyllin
Aranesp
Aranesp
Arava
Arestin
Arestin
Argatroban
Argatroban
Argatroban
Argatroban
Arginine
Arginine
Aricept
Aricept
Arimidex
Arimidex
Aripiprazole
Aripiprazole
Arixtra
Arixtra
Artane
Artane
Artemether
Artemether
Artemisinin
Artemisinin
Artesunate
Artesunate
Arthrotec
Arthrotec
Asacol
Ascorbic acid
Asmalix
Aspartame
Aspartic acid
Aspirin
Astemizole
Atacand
Atarax
Atehexal
Atenolol
Ativan
Atorvastatin
Atosiban
Atovaquone
Atridox
Atropine
Atrovent
Augmentin
Aureomycin
Avandia
Avapro
Avinza
Avizafone
Avobenzone
Avodart
Axid
Axotal
Azacitidine
Azahexal
Azathioprine
Azelaic acid
Azimilide
Azithromycin
Azlocillin
Azmacort
Aztreonam
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Some topical eye anesthetics are also used in otolaryngology, like for example oxybuprocaine.

Use of topical eye anesthetics in ophthalmology

Topical eye anesthetics are used in ophthalmology in order to numb the surface of the eye (the outermost layers of the cornea and conjunctiva) for the following purposes:

  • In order to perform a contact/applanation tonometry.
  • In order to perform a Schirmer's test (The Schirmer's test is sometimes used with a topical eye anesthetic, sometimes without. The use of a topical eye anesthetic might impede the reliability of the Schirmer's test and should be avoided if possible.).
  • In order to remove small foreign objects from the uppermost layer of the cornea or conjunctiva. The deeper and the larger a foreign object which should be removed lies within the cornea and the more complicated it is to remove it, the more drops of the topical eye anesthetic are necessary to be dropped onto the surface of the eye prior to the removal of the foreign object in order to numb the surface of the eye with enough intensity and duration.

Duration of topical eye anesthesia

The duration of topical eye anesthesia might depend on the type of the topical eye anesthetic and the amount of eye anesthetic being applied, but is usually about half an hour.

Abuse when used for pain relief

When used excessively, topical anesthetics can cause severe and irreversible damage to corneal tissues and even loss of the eye. The abuse of topical anesthetics often creates challenges for correct diagnosis in that it is a relatively uncommon entity that may initially present as a chronic keratitis masquerading as acanthamoeba keratitis or other infectious keratitis. When a keratitis is unresponsive to treatment and associated with strong ocular pain, topical anesthetic abuse should be considered, and a history of psychiatric disorders and other substance abuse have been implicated as important factors in the diagnosis. Because of the potential for abuse, clinicians have been warned about the possibility of theft and advised against prescribing topical anesthetics for therapeutic purposes.

Read more at Wikipedia.org


[List your site here Free!]


problem that wouldn't quit, The
From Optometric Management, 6/1/00 by Schmidt, Eric

When corneal erosion strikes again . . . and again

We've all seen cases in which the condition doesn't improve. Sometimes a more aggressive approach is needed, as in this case.

THE CASE: Martha, a 62-yearold, was hit in the left eye with a tree branch. She suffered a corneal foreign body and a large abrasion. She was treated at an eye clinic (not mine) and first presented to me 10 months later. Martha was taking atenolol (Tenormin) for hypertension. Her vision was mildly blurred OS and her pressing complaint was that this eye always felt sore.

Martha had no discharge but did have slight tearing OU. The soreness was worst in the morning, immediately upon waking, she said. During severe episodes, her lid felt as if it were "catching" on her eye. The problem had existed for 1 month.

Martha's exam

At the time of injury, Martha's eye was patched for 2 days. She'd used an antibiotic drop, but now used only artificial tears. Her vision at 10:30 a.m. was 20/20 -2 OD and 20/25 OS with her current prescription. Slitlamp exam showed a white, quiet anterior segment OD.

My exam of Martha's left eye revealed her problem. The central corneal surface was very irregular, with two small areas of negative staining and two larger areas that stained positively with NaFI (see figure below). The frankly, staining lesions indicated an absence of epithelium. I saw no foreign body and except for mild conjunctival injection, the rest of the exam was normal.

Martha had a severe, recurrent corneal erosion (RCE) OS that would probably require protracted treatment. I discussed treatment options with her and placed a tight-fitting disposable contact lens on her eye as a bandage. I prescribed ciprofloxacin hydrochloride (Ciloxan) OS q.i.d., telling Martha not to manipulate the contact lens and to use rewetting drops between applications of ciprofloxacin drops as often as possible. She was to return to see me in 1 week.

A classic

With recurrent episodes of acute ocular pain with tearing, photophobia and redness, Martha's case was a classic. These episodes are most common immediately upon opening the eyes when awakening. Chronic bouts of pain may present daily, or may be intermittent. The condition frequently arises after corneal trauma, particularly from an organic source such as a tree branch, or from a corneal abrasion. It may also result from a corneal dystrophy, such as epithelial basement membrane disease.

A localized disruption of the corneal epithelial layer marks the condition. There may be accompanying "roughening" or elevation of the corneal epithelium adjacent to the defect. Negative staining is typical of this roughening.

Because the defect usually fills in as the day goes on, you may not see any staining with the slit lamp. Generally, though, there's a positive staining defect that's surrounded by areas of loose or poorly adherent epithelium.

The saga continues

One week later Martha's left eye felt "real good" with the contact lens in, but after the technician removed the lens, her eye felt irritated. Her vision was still 20/25-1 OS. Her clinical exam revealed a small-staining area of RCE and two areas of roughened, elevated epithelium.

I inserted a new bandage contact lens in her left eye, and advised her to continue the ciprofloxacin q.i.d. and the rewetting drops as often as possible. I scheduled her for a 2-week follow-up visit.

At that visit, Martha's cornea was free of positive staining but showed a small area of negative staining. Her epithelium wasn't completely healed, so I inserted another contact lens in her left eye. I asked her to stop the ciprofloxacin but to continue artificial tears q.i.d.

Over the next 3 months, Martha's eye followed the pattern: It felt fine while a contact lens was in place, but irritation resumed after it was removed.

Examining again

At the 3-month visit, a Schirmer's test showed decreased tear production of 9 mm OD and 4 mm OS. Tear breakup time (TBUT) was also abnormal, measuring 5 seconds OD and 4 seconds OS. Although the RCE seemed to be improving, the dryness of her eyes would prevent complete resolution.

I inserted 0.5-mm Freemantype silicone punctal plugs in the lower punctum of each eye and reinserted a bandage lens OS.

At her 2-week post-plug follow-up, Martha said her eyes "hadn't felt this good in years." The cornea was wetting much better; there was no epithelial defect and only a small area of irregular tissue OS.

I didn't reinsert a contact lens but encouraged Martha to use nonpreserved artificial tears at least q.i.d. OU and hoped the saga was over.

Martha: the sequel

I saw Martha 6 months after inserting the punctal plugs. Her eyes were doing well, but once a month she felt a sharp pain OS, with redness. Each time, the pain would take 3 days to subside.

Martha admitted using the artificial tears only "as needed." The OS showed intrapalpebral conjunctival injection and a 2mm area of elevated, negatively staining corneal irregularities just inferior to the pupil margin.

TBUT was consistently 15 seconds OD but was diminished focally OS. The central, roughened area exhibited a TBUT of 2 seconds. The remainder of the left cornea had a TBUT of 11 seconds.

This showed that, although there were no apparent epithelial defects, the irregular cornea was precipitating intermittent episodes of RCE OS.

A more aggressive approach was definitely indicated. Because the epithelium wasn't loose, I didn't think debridement was appropriate. I discussed the anterior stromal puncture (ASP) technique with Martha, and she decided to undergo it.

One last try

To begin the procedure, I anesthetized the cornea with 1/2% topical proparacaine HCI (Alcaine). Using a disposable needle designed for ASP, I punctured the epithelium in 22 spots within the treatment zone of the eye.

Afterward, I instilled 1 drop of 1% cyclopentolate HCl (Cyclogyl), inserted a bandage contact lens and prescribed ciprofloxacin OS q4h. I discontinued the ciprofloxacin after 1 week and removed the contact lens 2 weeks later.

Martha tolerated the procedure well and now, over 1 year later remains symptom-free using artificial tears.

As you can see, RCE doesn't go down without a fight. Be persistent and aggressively treat this condition. Your patients' health and comfort depend on it.

Contributing Editor Eric Schmidt, O.D., is Director of the Bladen Eye Center in Elizabethtown, N.C. He can be reached via e-mail at KINZSEKATE@aol.com.

Copyright Boucher Communications, Inc. Jun 2000
Provided by ProQuest Information and Learning Company. All rights Reserved

Return to Alcaine
Home Contact Resources Exchange Links ebay